Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
all patients
cool environment plus supportive care
Overall, the only effective treatment and prevention is to avoid further sweating.[7]Haas N, Henz BM, Weigel H. Congenital miliaria crystallina. J Am Acad Dermatol. 2002 Nov;47(suppl 5):S270-2. http://www.ncbi.nlm.nih.gov/pubmed/12399748?tool=bestpractice.com In the setting of miliaria crystallina, a few hours in a cool environment will often bring relief.[10]Haas N, Martens F, Henz BM. Miliaria crystallina in an intensive care setting. Clin Exp Dermatol. 2004 Jan;29(1):32-4. http://www.ncbi.nlm.nih.gov/pubmed/14723716?tool=bestpractice.com
However, complete treatment of miliaria profunda can take avoidance of heat for weeks to months.[39]Lobitz WC Jr, Dobson L. Miliaria. Arch Environ Health. 1965 Oct;11(4):460-4. http://www.ncbi.nlm.nih.gov/pubmed/5838885?tool=bestpractice.com
Cool soothing baths with addition of colloidal oatmeal can be a helpful adjunct to soothe the skin.[38]James WD, Berger TG, Elston DM. Andrews' diseases of the skin clinical dermatology. 11th ed. Elsevier Inc., 2006.
Supportive care includes application of moisturising ointments such as anhydrous lanolin (applied before exercise or at onset of eruption and when required), regular cleansing of the skin, topical cornstarch powder (applied before exposure to hot/humid conditions and when required to treat eruption) or other absorbent powders, and ascorbic acid (vitamin C). Oral ascorbic acid is effective in the prevention and treatment of miliaria.[44]Hindson TC, Worsley DE. The effects of administration of ascorbic acid in experimentally induced miliaria and hypohidrosis in volunteers. Br J Dermatol. 1969;81:226-7. http://www.ncbi.nlm.nih.gov/pubmed/5775074?tool=bestpractice.com Topical treatment, such as chlorhexidine, may be added to a supportive care regimen.
Primary options
cool environment, moisturising ointment, topical absorbent powder and cleansing
and
ascorbic acid: children and adults: 1 g orally once daily
Secondary options
cool environment, moisturising ointment, topical absorbent powder and cleansing
and
ascorbic acid: children and adults: 1 g orally once daily
and
chlorhexidine topical: (2% to 4%) apply to the affected area for 15 seconds and rinse
antibacterial agents
Additional treatment recommended for SOME patients in selected patient group
Because of the possible causative role of Staphylococcus epidermidis in all forms of miliaria, topical antibacterials are another consideration especially for prophylaxis in at-risk patients.[18]Holzle E, Kligman AM. The pathogenesis of miliaria rubra. Role of the resident microflora. Br J Dermatol. 1978 Aug;99(2):117-37. http://www.ncbi.nlm.nih.gov/pubmed/698101?tool=bestpractice.com
Topical antibacterials used in studies include bacitracin, chloramphenicol, erythromycin, neomycin, polymyxin, and chlorhexidine.
These antibacterials, when used prophylactically, reduced the formation of experimentally induced miliaria.[18]Holzle E, Kligman AM. The pathogenesis of miliaria rubra. Role of the resident microflora. Br J Dermatol. 1978 Aug;99(2):117-37. http://www.ncbi.nlm.nih.gov/pubmed/698101?tool=bestpractice.com [39]Lobitz WC Jr, Dobson L. Miliaria. Arch Environ Health. 1965 Oct;11(4):460-4. http://www.ncbi.nlm.nih.gov/pubmed/5838885?tool=bestpractice.com [40]Stillman MA, Hindson TC, Maibach HI. The effect of pretreatment of skin on artificially induced miliaria rubra and hypohidrosis. Br J Dermatol. 1971 Feb;84(2):110-6. http://www.ncbi.nlm.nih.gov/pubmed/4926865?tool=bestpractice.com However, their use in the treatment of established miliaria has not been clearly demonstrated.[1]Wenzel FG, Horn TD. Nonneoplastic disorders of the eccrine glands. J Am Acad Dermatol. 1998 Jan;38(1):1-17; quiz 18-20. http://www.ncbi.nlm.nih.gov/pubmed/9448199?tool=bestpractice.com [18]Holzle E, Kligman AM. The pathogenesis of miliaria rubra. Role of the resident microflora. Br J Dermatol. 1978 Aug;99(2):117-37. http://www.ncbi.nlm.nih.gov/pubmed/698101?tool=bestpractice.com
Primary options
bacitracin/neomycin/polymyxin B topical: apply to the affected area(s) two to three times daily
OR
bacitracin/neomycin/polymyxin B/pramoxine topical: apply to the affected area(s) two to three times daily
OR
bacitracin/polymyxin B topical: apply to the affected area(s) two to three times daily
OR
erythromycin topical: apply to the affected area(s) twice daily
OR
neomycin/polymyxin B/pramoxine topical: apply to the affected area(s) two to three times daily
antipyretics
Treatment recommended for ALL patients in selected patient group
Used to lower the temperature of a febrile patient with miliaria (especially miliaria crystallina).[45]Khosla R, Guntupalli KK. Heat-related illnesses. Crit Care Clin. 1999 Apr;15(2):251-63. http://www.ncbi.nlm.nih.gov/pubmed/10331127?tool=bestpractice.com
Primary options
paracetamol: children: 10-15 mg/kg orally every 4-6 hours when required, maximum 75 mg/kg/day; adults: 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
ibuprofen: children: 5 mg/kg orally every 4-6 hours when required, maximum 40 mg/kg/day; adults: 400-800 mg orally every 6-8 hours when required, maximum 2400 mg/day
antipruritic agents
Treatment recommended for ALL patients in selected patient group
Patients with pruritus associated with miliaria rubra should apply soothing agents such as calamine lotion, menthol, or pramoxine.
When these are not effective, or for more severe cases, a mid-potency corticosteroid such as triamcinolone may be used.[48]Lebwohol MG, Heymann WR, Berth-Jones J, et al. Treatment of skin disease comprehensive therapeutic strategies. 2nd ed. St Louis, MO: Mosby; 2006.
Primary options
calamine lotion topical: children and adults: apply to the affected area(s) when required
OR
menthol/petrolatum topical: children and adults: apply to the affected area(s) when required
OR
pramocaine topical: children >2 years of age and adults: (1%) apply to the affected area(s) up to four times daily when required
Secondary options
triamcinolone topical: children and adults: (0.1%) apply to affected area(s) twice daily
isotretinoin
Additional treatment recommended for SOME patients in selected patient group
Although isotretinoin use has been associated with the formation of miliaria crystallina, a short course can be effective in the treatment of miliaria.[4]Kirk JF, Wilson BB, Chun W, et al. Miliaria profunda. J Am Acad Dermatol. 1996 Nov;35(5 Pt 2):854-6. http://www.ncbi.nlm.nih.gov/pubmed/8912605?tool=bestpractice.com [23]Gupta AK, Ellis CN, Madison KC, et al. Miliaria crystallina occurring in a patient treated with isotretinoin. Cutis. 1986 Oct;38(4):275-6. http://www.ncbi.nlm.nih.gov/pubmed/3465509?tool=bestpractice.com [43]Simon NS, Fullen DR, Helfrich YR. Goosefleshlike lesions and hypohidrosis. Arch Dermatol. 2007 Oct;143(10):1323-8. http://www.ncbi.nlm.nih.gov/pubmed/17938352?tool=bestpractice.com
Anecdotal evidence suggests that treatment of miliaria profunda with isotretinoin induced improvement; however, this is not conclusive as treatment was administered concomitantly with topical anhydrous lanolin.[4]Kirk JF, Wilson BB, Chun W, et al. Miliaria profunda. J Am Acad Dermatol. 1996 Nov;35(5 Pt 2):854-6. http://www.ncbi.nlm.nih.gov/pubmed/8912605?tool=bestpractice.com
Due to teratogenicity women must undergo pregnancy testing before starting the medicine and monthly while the medicine is being taken.
Prescribing restrictions vary globally; for example, in the US, isotretinoin can only be prescribed under the iPledge system, whereas in the UK, it is prescribed only under consultant supervision; local guidelines should always be followed. iPledge system for prescribing isotretinoin Opens in new window
FBC, lipid panel, and liver function tests are monitored regularly in all patients taking isotretinoin. Women who can potentially fall pregnant also require monthly pregnancy tests.
Primary options
isotretinoin: adults: 0.5 mg/kg/day orally for 2 months
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer